Therefore, tumor specificity is achieved by placing the E1A gene under transcriptional regulation of a tumor specific promoter [52], CXCR4 in breast cancer and prostate specific antigen (PSA) promoter in prostate cancer [53, 54]. The gene discussed is KLK3; the disease is prostate cancer.